Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Untersuchungen an Wurstbr tproben zur Bildung von N?-Carboxymethyllysin
Zeitschrift f r Lebensmittel-Untersuchung und -Forschung, 1995-01, Vol.201 (1), p.27-29
1995
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Modelluntersuchungen zu Bedingungen der Bildung vonN ?-Carboxymethyllysin in Lebensmitteln
Zeitschrift f r Lebensmittel-Untersuchung und -Forschung, 1994-01, Vol.198 (1), p.15-19
1994
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Development of control strategies for high cell density cultivations
Mathematics and computers in simulation, 1994-01, Vol.37 (2), p.153-164
1994
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value
British journal of cancer, 2023-05, Vol.128 (9), p.1742-1752
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023
Breast care (Basel, Switzerland), 2023-08, Vol.18 (4), p.306-315
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies
Breast cancer research and treatment, 2014-11, Vol.148 (1), p.143-151
2014
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells—The DETECT III Clinical Trial
Clinical chemistry (Baltimore, Md.), 2024-01, Vol.70 (1), p.307-318
2024
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany
BMC cancer, 2020-11, Vol.20 (1), p.1091-1091, Article 1091
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Cancers, 2018-12, Vol.11 (1), p.10
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023
Breast care (Basel, Switzerland), 2023-08, Vol.18 (4), p.289-305
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany
Breast (Edinburgh), 2020-12, Vol.54, p.88-95
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Return of individual genomic research results within the PRAEGNANT multicenter registry study
Breast cancer research and treatment, 2023-01, Vol.197 (2), p.355-368
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry
Breast (Edinburgh), 2018-02, Vol.37, p.42-51
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Update Breast Cancer 2017 – Implementation of Novel Therapies
Geburtshilfe und Frauenheilkunde, 2017-12, Vol.77 (12), p.1281-1290
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer
European journal of cancer (1990), 2024-02, Vol.198, p.113480-113480, Article 113480
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PD3-12: Efficacy of the tyrosine kinase inhibitor lapatinib in the treatment of patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells - results from the randomized phase III DETECT III trial
Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD3-12-PD3-12
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2− metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
Annals of oncology, 2023-08, Vol.34 (8), p.660-669
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Corrigendum to “Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany”
Breast (Edinburgh), 2021-02, Vol.55, p.138-139
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P2-13-03: KEYRICHED-1 - A prospective, multicenter, open label, neoadjuvant phase II single arm study with pembrolizumab in combination with dual anti-HER2 blockade with trastuzumab and pertuzumab in early breast cancer patients with molecular HER2-enriched intrinsic subtype
Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-13-03
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PD10-11: Keyriched-1- A prospective, multicenter, open label, neoadjuvant phase ii single arm study with pembrolizumab in combination with dual anti-HER2 blockade with trastuzumab and pertuzumab in early breast cancer patients with molecular HER2-enriched intrinsic subtype
Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD10-11-PD10-11
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Update Breast Cancer 2020 Part 2 – Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics
Geburtshilfe und Frauenheilkunde, 2020-04, Vol.80 (4), p.391-398
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers
Journal of cancer research and clinical oncology, 2022-03, Vol.148 (3), p.719-726
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Update Breast Cancer 2020 Part 1 – Early Breast Cancer: Consolidation of Knowledge About Known Therapies
Geburtshilfe und Frauenheilkunde, 2020-03, Vol.80 (3), p.277-287
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab
Cancers, 2020-10, Vol.12 (10), p.3021
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Update Breast Cancer 2020 Part 3 – Early Breast Cancer
Geburtshilfe und Frauenheilkunde, 2020-11, Vol.80 (11), p.1105-1114
2020
Volltextzugriff (PDF)
1 – 25 von 43
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen